The new lidocaine ointment that Chinese company has declared to the US FDA has been approved. This means that the applicant can produce and sell the product in the US market. It has been determined that the 5% therapeutic effect of lidocaine ointment is equivalent to the original research (RLD) lercaine ointment listed by AstraZeneca. Lidocaine, also known as Xylocaine, …